Business EconomyPosted at: Jun 13 2026 7:01PM


Dr Reddy's launches Generic Bosutinib Tablets in US market

Hyderabad, June 13 (UNI) Dr Reddy's Laboratories Ltd on Saturday announced the launch of Bosutinib Tablets 400 mg, a generic equivalent of Bosulif, in the United States, marking its entry as the first generic player in the market for the strength and further expanding its oncology portfolio.
The Hyderabad-based pharmaceutical major said it has partnered with MSN Laboratories Pvt Ltd. for the product. Under the collaboration, Dr Reddy's holds exclusive marketing rights in the United States, while MSN is responsible for product development and manufacturing.
Bosutinib Tablets 400 mg was a first-to-file product and is eligible for 180 days of generic drug exclusivity in the US market, the company said in a statement.
Commenting on the launch, Milan Kalawadia, Chief Executive Officer, North America, Dr Reddy's Laboratories Inc., said the introduction of the product reflects the company's strategy of ensuring timely market entry for high-priority therapies while improving access to affordable treatment options.
"This launch underscores our commitment to expanding access to critical medicines and strengthening our oncology portfolio while supporting patients and healthcare providers with affordable treatment alternatives," he said.
MSN Laboratories Executive Director Bharat Reddy said the successful development and commercialisation of Bosutinib Tablets highlights the company's scientific, regulatory and manufacturing capabilities in complex oncology products.
"We remain committed to delivering high-quality and affordable medicines globally through efficient product development and manufacturing excellence," he said.
According to IQVIA National Sales Perspectives data, the Bosulif brand of Bosutinib Tablets 400 mg recorded sales of approximately USD 253.8 million in the United States during the 12-month period ended April 2026.
UNI KNR SAS
Please log in to get detailed story.
Tags: #Dr Reddy's launches Generic Bosutinib Tablets in US market
More News

Revanth Reddy announces land for FICCI, reaffirms push for women-led entrepreneurship

18 Jul 2026 | 6:58 PM

Hyderabad, July 18 (UNI) Telangana Chief Minister A Revanth Reddy on Saturday reiterated his government's commitment to women-led development, announcing the allocation of 1,000 square yards of land near Shilparamam in Hitech City for the Federation of Indian Chambers of Commerce and Industry (FICCI) to establish its headquarters and one acre in Bharat Future City to make the organisation a partner in the State's flagship development project.

see more..

Kotak dismisses margin pressure concerns after 26 pc Q1 profit jump

18 Jul 2026 | 5:43 PM

Mumbai, July 18 (UNI) Kotak Mahindra Bank on Saturday sought to allay investor concerns over the quality of its June-quarter earnings after reporting a 26 per cent rise in standalone net profit to ₹4,123 crore, saying its net interest margins (NIM) had stabilised following the Reserve Bank of India's repo rate cycle and that earnings were driven by underlying operating strength rather than merely lower provisioning.

see more..

Kotak Mahindra Bank Q1 profit rises 26 pc as NPAs fall

18 Jul 2026 | 4:17 PM

Mumbai, July 18 (UNI) Kotak Mahindra Bank reported a strong start to the financial year with a 26 per cent jump in standalone net profit to ₹4,123 crore in the first quarter of FY27, supported by robust credit growth, higher deposits and a sharp improvement in asset quality.

see more..

India Inc’s spending on CSR hits Rs 40,794 cr in FY2024-25: Report

18 Jul 2026 | 4:05 PM

New Delhi, Jul 18 (UNI) India Inc's spending on Corporate Social Responsibility (CSR) touched a record high of Rs 40,794 crore in FY2024-25, registering a 17pc year-on-year increase, as companies continued to expand investments in education, healthcare and sustainability, according to the Bharat CSR Performance Report 2026 released by consulting and research firm Fulcrum.

see more..

Hesitation biggest obstacle to business success, Sitharaman urges young entrepreneurs to take risks

18 Jul 2026 | 3:46 PM

New Delhi, Jul 18 (UNI) Finance Minister Nirmala Sitharaman on Saturday called upon India's young entrepreneurs to overcome their fear of taking risks, saying the biggest obstacle to business success today is not geography or lack of opportunity, but hesitation.

see more..